Company registration number 09609006 (England and Wales)
NEL HEALTHCARE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
NEL HEALTHCARE LIMITED
CONTENTS
Page
Statement of financial position
1 - 2
Notes to the financial statements
3 - 8
NEL HEALTHCARE LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
481,099
578,746
Tangible assets
4
116,608
131,791
597,707
710,537
Current assets
Stocks
5,000
5,000
Debtors
5
45,510
174,339
Cash at bank and in hand
72,969
56,155
123,479
235,494
Creditors: amounts falling due within one year
6
(194,197)
(308,810)
Net current liabilities
(70,718)
(73,316)
Total assets less current liabilities
526,989
637,221
Creditors: amounts falling due after more than one year
7
-
(57,452)
Provisions for liabilities
(18,881)
(21,668)
Net assets
508,108
558,101
Capital and reserves
Called up share capital
100
100
Share premium account
117
-
0
Profit and loss reserves
507,891
558,001
Total equity
508,108
558,101
NEL HEALTHCARE LIMITED
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT
31 MARCH 2025
31 March 2025
- 2 -

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company has elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 5 November 2025 and are signed on its behalf by:
Dr C P Nel
Director
Company registration number 09609006 (England and Wales)
NEL HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
1
Accounting policies
Company information

Nel Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is 7-9 The Avenue, Eastbourne, East Sussex, BN21 3YA.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover represents amounts receivable for dental services and counter sales. The company is not registered for VAT.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue derived from all private dental work is recognised based upon the stage of completion reached during the course of treatment.

Revenue derived from all NHS dental work is recognised based upon the volume of dental activity delivered in the financial year. In accordance with the company’s NHS contract, where there is under-delivery against its target activity levels there will be potential clawback by the NHS and a creditor is recognised for this.

1.3
Intangible fixed assets - goodwill

Acquired goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.

1.4
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Website design
10% reducing balance
NEL HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -
1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Land and buildings leasehold
straight line over length of lease
Fixtures, fittings and equipment
25% reducing balance
Computer equipment
33% reducing balance
Motor vehicles
25% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

NEL HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 5 -
Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.12
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.13
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

NEL HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 6 -
1.14
Leases
As lessee

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the statement of financial position as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

1.15
Government grants

Government grants are recognised at the fair value of the asset receive d or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
10
9
3
Intangible fixed assets
Goodwill
Website design
Total
£
£
£
Cost
At 1 April 2024 and 31 March 2025
970,311
6,120
976,430
Amortisation and impairment
At 1 April 2024
392,586
5,099
397,686
Amortisation charged for the year
97,031
614
97,645
At 31 March 2025
489,618
5,713
495,331
Carrying amount
At 31 March 2025
480,692
407
481,099
At 31 March 2024
577,725
1,021
578,746
NEL HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 7 -
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 April 2024
154,260
214,568
368,828
Additions
-
0
9,290
9,290
Disposals
-
0
(5,394)
(5,394)
At 31 March 2025
154,260
218,464
372,724
Depreciation and impairment
At 1 April 2024
109,141
127,896
237,038
Depreciation charged in the year
4,036
20,288
24,324
Eliminated in respect of disposals
-
0
(5,246)
(5,246)
At 31 March 2025
113,177
142,939
256,116
Carrying amount
At 31 March 2025
41,083
75,525
116,608
At 31 March 2024
45,119
86,672
131,791
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
12,324
13,692
Corporation tax recoverable
-
0
127,690
Amounts owed by group undertakings
151
-
0
Other debtors
33,035
32,957
45,510
174,339
6
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans and overdrafts
56,508
86,316
Trade creditors
24,269
16,699
Corporation tax
88,572
71,499
Other taxation and social security
5,913
4,990
Other creditors
18,935
129,306
194,197
308,810
NEL HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
6
Creditors: amounts falling due within one year
(Continued)
- 8 -

There is a fixed and floating charge over the leasehold property known as Ground Floor, Tricon House, Coffee House Yard, London Road, Sevenoaks, Kent, TN13 1AH.

There is also a fixed and floating charge over all property or undertaking of the company.

7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
-
0
55,927
Other creditors
-
0
1,525
-
0
57,452
8
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
2024
£
£
Total commitments
250,244
308,844
2025-03-31 2024-04-01 false false false 05 November 2025 CCH Software CCH Accounts Production 2025.200 No description of principal activity Dr C P Nel Dr A J Schutte Dr A J Schutte 09609006 2024-04-01 2025-03-31 09609006 2025-03-31 09609006 2024-03-31 09609006 core:NetGoodwill 2025-03-31 09609006 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2025-03-31 09609006 core:NetGoodwill 2024-03-31 09609006 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2024-03-31 09609006 core:LandBuildings 2025-03-31 09609006 core:OtherPropertyPlantEquipment 2025-03-31 09609006 core:LandBuildings 2024-03-31 09609006 core:OtherPropertyPlantEquipment 2024-03-31 09609006 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 09609006 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 09609006 core:ShareCapital 2025-03-31 09609006 core:ShareCapital 2024-03-31 09609006 core:SharePremium 2025-03-31 09609006 core:SharePremium 2024-03-31 09609006 core:RetainedEarningsAccumulatedLosses 2025-03-31 09609006 core:RetainedEarningsAccumulatedLosses 2024-03-31 09609006 bus:Director1 2024-04-01 2025-03-31 09609006 core:Goodwill 2024-04-01 2025-03-31 09609006 core:IntangibleAssetsOtherThanGoodwill 2024-04-01 2025-03-31 09609006 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2024-04-01 2025-03-31 09609006 core:LandBuildings core:LongLeaseholdAssets 2024-04-01 2025-03-31 09609006 core:FurnitureFittings 2024-04-01 2025-03-31 09609006 core:ComputerEquipment 2024-04-01 2025-03-31 09609006 core:MotorVehicles 2024-04-01 2025-03-31 09609006 2023-04-01 2024-03-31 09609006 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2024-03-31 09609006 2024-03-31 09609006 core:NetGoodwill 2024-04-01 2025-03-31 09609006 core:LandBuildings 2024-03-31 09609006 core:OtherPropertyPlantEquipment 2024-03-31 09609006 core:LandBuildings 2024-04-01 2025-03-31 09609006 core:OtherPropertyPlantEquipment 2024-04-01 2025-03-31 09609006 core:CurrentFinancialInstruments 2025-03-31 09609006 core:CurrentFinancialInstruments 2024-03-31 09609006 core:WithinOneYear 2025-03-31 09609006 core:WithinOneYear 2024-03-31 09609006 core:Non-currentFinancialInstruments 2025-03-31 09609006 core:Non-currentFinancialInstruments 2024-03-31 09609006 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09609006 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 09609006 bus:FRS102 2024-04-01 2025-03-31 09609006 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 09609006 bus:Director2 2024-04-01 2025-03-31 09609006 bus:CompanySecretary1 2024-04-01 2025-03-31 09609006 bus:FullAccounts 2024-04-01 2025-03-31 xbrli:pure xbrli:shares iso4217:GBP